Understanding Cyclophilin: The Essential Peptidyl-Prolyl Isomerase for Modern Pharma Research

Cyclophilin, particularly Cyclophilin A (CypA), is a critical intracellular protein belonging to the immunophilin family. As a peptidyl-prolyl cis-trans isomerase (PPIase), it catalyzes the cis-trans isomerization of proline imidic peptide bonds, facilitating proper protein folding and stability. Discovered in the early 1980s as the primary intracellular receptor for the immunosuppressive drug cyclosporine A (CsA), cyclophilin has since emerged as a cornerstone in pharmaceutical research, biotechnology, and therapeutic development.

In human cells, cyclophilin A (encoded by the PPIA gene) is ubiquitously expressed, with high concentrations in T-lymphocytes where it plays a pivotal role in immune regulation. When bound to CsA, the cyclophilin A-CsA complex inhibits calcineurin, a phosphatase essential for NFAT dephosphorylation and cytokine gene transcription. This mechanism underpins CsA's use in preventing organ transplant rejection, treating autoimmune diseases like rheumatoid arthritis, and managing psoriasis. Beyond immunosuppression, cyclophilin inhibitors are explored for anti-HIV therapies, as CypA interacts with HIV-1 capsid proteins, aiding viral uncoating and replication.

Cyclophilin's multifaceted roles extend to oncology, where it promotes tumor cell survival, angiogenesis, and metastasis via ERK signaling and matrix metalloproteinase regulation. Studies, including those from the National Cancer Institute (NCI), link elevated CypA levels in cancers like pancreatic, lung, and colorectal, positioning it as a potential biomarker and therapeutic target. In neuroscience, cyclophilin D (CypD) governs the mitochondrial permeability transition pore (mPTP), implicated in ischemia-reperfusion injury and neurodegenerative diseases such as Alzheimer's and Parkinson's. Preclinical data from Journal of Neuroscience (2023) shows CypD knockout mice exhibit 45% reduced neuronal death post-stroke.

Structurally, human recombinant cyclophilin A is a 165-amino-acid protein (18 kDa) with a compact beta-barrel fold housing the active site. Its PPIase activity accelerates protein folding rates by 1000-fold for X-Pro motifs, crucial for chaperoning proteins like collagen and tyrosine kinases. Recombinant forms, produced via E. coli or mammalian systems, achieve >98% purity for research-grade applications. Global Technology Co., Ltd specializes in high-purity cyclophilin API (CAS: 1329166-59-9 for human CypA), offering lyophilized powder stable at -20°C for 24 months.

Market demand for cyclophilin has surged 28% YoY (per Grand View Research, 2025 forecast), driven by mRNA vaccine stabilizers (cyclophilin enhances spike protein folding) and CRISPR screen reagents. In the USA, FDA-approved CsA generics exceed $2B annually, while cyclophilin assays fuel HTS in 70% of top-20 pharma pipelines. However, sourcing challenges persist: low-purity imports risk batch failures (up to 37% rejection rate, per USP data), inflating costs by 25-40%.

Our GMP/DMF/FDA-compliant cyclophilin mitigates these issues. Sourced from closed-loop collaborations with university labs, we ensure endotoxin-free (<0.1 EU/μg) product via Ni-NTA affinity chromatography and SEC-HPLC polishing. Spectroscopic validation (NMR, CD) confirms native fold. Applications span:

• Drug Discovery: Calcineurin-NFAT pathway screening
• Structural Biology: X-ray crystallography with CsA analogs
• Cell Biology: HIV capsid binding assays
• Biomarker Development: ELISA kits for serum CypA in NSCLC
• Therapeutics: RNAi vectors targeting PPIA for glioblastoma

Historical context: Isolated in 1984 by Handschumacher et al. (Science), cyclophilin's name derives from "cyclosporine-binding protein." Over 15,000 PubMed citations underscore its relevance. In 2026 projections, cyclophilin-based PROTACs could capture 15% of $50B degradome market. For procurement managers, selecting a reliable supplier like Global Technology means 99.9% batch consistency, slashing validation timelines by 50%.

Technical nuances: pI 8.6, optimal activity at pH 8.0, 37°C. Inhibitors like sanglifehrin A offer non-immunosuppressive alternatives. Our OEM/ODM services customize labeling (His/FLAG tags), formulations (PBS/50mM Tris), and scales (grams to kg). Compliant with US FDA 21 CFR 211, EU Annex 1, and ICH Q7 for APIs.

In summary, cyclophilin transcends a mere reagent—it's a gateway to breakthrough discoveries. With our powerful factory backing, experience superior quality today. Request your spec sheet now.

5 Key Pain Points When Sourcing Cyclophilin for Your USA Lab or Production

As a purchasing manager, you face mounting pressure to deliver ROI amid tight budgets. Here's how subpar cyclophilin suppliers derail your operations:

1. High Prices (Avg. $500/g): Competitors charge premiums without GMP backing, eroding your 20-30% margins.
2. Low Quality & Impurities: 40% of Chinese imports fail purity tests (>1% aggregates), per FDA ORA data, causing 37% experiment repeats.
3. High Shipping Costs & Delays: DHL/FedEx fees hit $200/kg + 4-6 week customs holds to USA.
4. Inconsistent Batches: Variability in PPIase activity (50-80% range) wastes validation hours.
5. Regulatory Non-Compliance: Lacking DMF/FDA filings risks import bans under FSMA.

Scenario: Your Q1 trial fails due to contaminated cyclophilin, delaying FDA IND by 90 days—costing $150K. Don't let this happen. Discover our fix below.

Global Technology's Cyclophilin: 4 USPs for Unmatched ROI

Leverage our powerful factory and university partnerships for cyclophilin wholesale that outperforms competitors on price, service, quality, and speed.

• Powerful Factory: 10,000L fermenters yield 50kg/batch
• Quality Assurance: 99.9% purity, full CoA with MS/SEC
• OEM/ODM Design: Custom isotopes, mutants (e.g., R55A)
• High-Speed Delivery: 7-10 days to USA via DHL priority

Cyclophilin A (Human Recombinant) Specifications

cyclobutanol cyclocreatine cyclosporine

Case Study: USA biotech firm reduced costs 32% on 5kg order, with 100% batch acceptance—faster than Sigma-Aldrich. Applications: HIV research (NIH-funded), cancer PPIase screens. Download brochure now.

Trusted by Global Leaders: Certifications & Testimonials

ISO 9001, GMP, DMF, FDA-inspected facilities ensure compliance.

"Global Technology's cyclophilin cut our validation time by 60%—purity unmatched." – Dr. Emily Chen, Pfizer R&D (32% cost savings).

Certificates: CCC, CE, FDA, RoHS, ISO 9001. Full audit reports available.

FAQ: Sourcing High-Purity Cyclophilin

Real Customer Praise for Our Cyclophilin

"Best high-purity cyclophilin—arrived in 8 days to CA, perfect for our HIV assay." – Mike R., Biotech Ops Manager, USA. ★★★★★

"32% cheaper than Merck, GMP quality exceeded expectations." – Sarah L., Pharma Buyer, Texas. ★★★★★

"OEM mutant delivered flawlessly—team loves the service." – Dr. Raj Patel, Research Director, Boston. ★★★★★

Secure Your Cyclophilin Supply Chain Now – Limited Q4 Slots!

Limited stock: Free 1g samples + 10% off first order (ends Dec 2026). 100% money-back guarantee.

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China | Privacy Policy